Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln
This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US |
| description | This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = O (C 0.385, methanol); LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol); |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE3889417TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE3889417TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE3889417TT23</originalsourceid><addsrcrecordid>eNqNyj0KwkAQhuE0FqLeYTyAhUZQS9GIIHbBNuTnS3bJOhNmNx7Nyi4X0yIHsHp54ZlGxR3BSAWqh49SZUE34aDiHOglTKVRYetLA6VjePbc-FZzbg1soJ4rYrQqYRQJB6j9HRWw9BjeDRzPo0mdO4_F2Fm0vCTp6bpCJxl8l5dghOycxPv9Ybvepekm_sd8AVOwQGM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln</title><source>esp@cenet</source><creator>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US ; GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US ; TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US ; CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US ; GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US ; BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</creator><creatorcontrib>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US ; GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US ; TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US ; CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US ; GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US ; BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</creatorcontrib><description>This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = O (C 0.385, methanol); LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);</description><edition>5</edition><language>ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; FODDER ; FOODS OR FOODSTUFFS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES ; VINEGAR ; WINE</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941201&DB=EPODOC&CC=DE&NR=3889417T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941201&DB=EPODOC&CC=DE&NR=3889417T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US</creatorcontrib><creatorcontrib>GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US</creatorcontrib><creatorcontrib>TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US</creatorcontrib><creatorcontrib>CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US</creatorcontrib><creatorcontrib>GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US</creatorcontrib><creatorcontrib>BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</creatorcontrib><title>Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln</title><description>This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = O (C 0.385, methanol); LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>FODDER</subject><subject>FOODS OR FOODSTUFFS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyj0KwkAQhuE0FqLeYTyAhUZQS9GIIHbBNuTnS3bJOhNmNx7Nyi4X0yIHsHp54ZlGxR3BSAWqh49SZUE34aDiHOglTKVRYetLA6VjePbc-FZzbg1soJ4rYrQqYRQJB6j9HRWw9BjeDRzPo0mdO4_F2Fm0vCTp6bpCJxl8l5dghOycxPv9Ybvepekm_sd8AVOwQGM</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US</creator><creator>GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US</creator><creator>TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US</creator><creator>CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US</creator><creator>GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US</creator><creator>BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</creator><scope>EVB</scope></search><sort><creationdate>19941201</creationdate><title>Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln</title><author>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US ; GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US ; TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US ; CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US ; GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US ; BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE3889417TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1994</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>FODDER</topic><topic>FOODS OR FOODSTUFFS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US</creatorcontrib><creatorcontrib>GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US</creatorcontrib><creatorcontrib>TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US</creatorcontrib><creatorcontrib>CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US</creatorcontrib><creatorcontrib>GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US</creatorcontrib><creatorcontrib>BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US</au><au>GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US</au><au>TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US</au><au>CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US</au><au>GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US</au><au>BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln</title><date>1994-12-01</date><risdate>1994</risdate><abstract>This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = O (C 0.385, methanol); LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);</abstract><edition>5</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DE3889417TT2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE FODDER FOODS OR FOODSTUFFS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE |
| title | Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MAIESE,%20WILLIAM%20MICHAEL,%20BRIDGEWATER%20NEW%20JERSEY%2008807,%20US&rft.date=1994-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE3889417TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |